Replimune Group, Inc.
—- Market cap
- —
- Debt
- +$83.31M
- Cash
- −$268.89M
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $1.10T · View financials
Decision snapshot: REPL stock price vs AVGO: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AVGO's multiple
Needs Revenue / share.
Implied fair value · at REPL's multiple
Needs REPL P/S.
Metric by metric
Live quote
As of 2024-12-31
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: REPL FY 2026 (ended Mar 31, 2026) · AVGO FY 2025 (ended Nov 2, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 94% equity / 6% debt · EV / Revenue 18.03x · EV / EBITDA 30.32x
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
REPLIMUNE GROUP, INC. · implied price per share
Cash flow and years must be positive.
Broadcom Inc. · implied price per share
Bear
$51.89
Base
$61.05
Bull
$70.21
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.50x
0.80x
Net debt / EBITDA
Leverage against operating earnings
0.60x
1.29x
Cash and equivalents
Liquid reserves on the balance sheet
$268.89M
$16.18B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMGEN INC
REPL vs AMGN
INCYTE CORP
REPL vs INCY
Blueprint Medicines Corp
REPL vs BPMC
Adaptive Biotechnologies Corp
REPL vs ADPT
NVIDIA Corporation
REPL vs NVDA
Intel Corporation
REPL vs INTC
Advanced Micro Devices, Inc.
REPL vs AMD
QUALCOMM Incorporated
REPL vs QCOM
Cisco Systems, Inc.
REPL vs CSCO
$83.31M
$65.14B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.